Table 6 Multivariable analysis of factors associated with MACCE among type 2 diabetes and non-type 2 diabetes patients who underwent bioprosthetic mitral valve replacement
T2DM | Non-T2DM | Both | ||||
|---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age | 1.03 (1.01–1.05) | 0.013 | 1.02 (1.01–1.03) | 0.003 | 1.02 (1.01–1.03) | 0.002 |
Female sex | 1.03 (0.73–1.44) | 0.677 | 1.27 (1.08–1.49) | 0.009 | 1.21 (1.04–1.39) | 0.008 |
Coronary artery bypass graft | 1.54 (1.07–2.21) | 0.020 | 1.74 (1.45–2.08) | < 0.001 | 1.71 (1.45–2.00) | < 0.001 |
Intra-aortic balloon counter-pulsation | 9.64 (5.60–16.58) | < 0.001 | 9.21 (7.01–12.09) | < 0.001 | 9.46 (7.41–12.06) | < 0.001 |
Pacemaker implantation | 0.39 (0.16–0.90) | 0.029 | 0.46 (0.32–0.67) | < 0.001 | 0.44 (0.32–0.62) | < 0.001 |
Blood transfusion | NS | NS | 1.36 (1.16–1.60) | < 0.001 | 1.36 (1.18–1.58) | < 0.001 |
Acute renal disease | 3.67 (2.56–5.28) | < 0.001 | 3.01 (2.54–3.57) | < 0.001 | 3.00 (2.57–3.50) | < 0.001 |
Congestive heart failure | 2.30 (1.65–3.22) | < 0.001 | 1.82 (1.56–2.13) | < 0.001 | 1.89 (1.64–2.18) | < 0.001 |
Atrial fibrillation | 0.66 (0.48–0.93) | 0.017 | 0.59 (0.50–0.68) | < 0.001 | 0.59 (0.52–0.68) | < 0.001 |
Pulmonary hypertension | NS | NS | 0.83 (0.70–0.98) | 0.031 | 0.84 (0.72–0.99) | 0.034 |
Obesity | NS | NS | 0.54 (0.36–0.82) | 0.004 | 0.66 (0.48–0.91) | 0.011 |
Endocarditis | NS | NS | 1.49 (1.25–1.79) | < 0.001 | 1.49 (1.27–1.75) | < 0.001 |
Pneumonia | 2.91 (1.33–6.37) | 0.007 | 2.96 (2.19–4.03) | < 0.001 | 3.00 (2.26–3.99) | < 0.001 |
Renal disease | 1.61 (1.05–2.46) | 0.029 | NS | NS | 1.27 (1.04–1.56) | 0.021 |
Liver disease | 2.58 (1.29–5.17) | 0.007 | 3.22 (2.36–4.40) | < 0.001 | 3.09 (2.33–4.11) | < 0.001 |
Year | 0.95 (0.91–0.99) | 0.018 | 0.93 (0.92–0.95) | < 0.001 | 0.93 (0.92–0.95) | < 0.001 |
T2DM | NS | NS | NS | NS | 0.88 (0.74–1.05) | 0.172 |